Keyphrases
African American
6%
After Surgery
6%
American Cancer Society
6%
Anti-apoptotic Proteins
6%
B-cell Lymphoma 2 (Bcl-2)
6%
BRCA Genes
12%
Breast Cancer
18%
Cancer Experience
6%
Cancer Mortality
6%
Cell Death
12%
Cellular Immune Response
6%
Chlorin e6
37%
Clinical Care
6%
Conventional Chemotherapy
6%
Conventional Radiation Therapy
12%
Early-stage Triple-negative Breast Cancer
12%
Effective Treatment
6%
High Risk
6%
Hispanic Ethnicity
6%
Human Epidermal Growth Factor Receptor 2 (HER2)
6%
Hybrid Nanoparticles
100%
Immune Response
6%
Immunological Effects
12%
Mechanism of Death
12%
Metastases to Lung
12%
Metastasis
12%
Metastasis Risk
6%
Nanoparticles
12%
Novel Therapeutics
6%
Nucleic Acid Therapeutics
6%
Orthotopic Model
6%
Overcoming Resistance
6%
Photodynamic Therapy
6%
Photosensitizing Agents
12%
Poor Prognosis
6%
Prevent Recurrence
6%
Proliferative Activity
6%
Radiation Therapy
6%
Relapse Risk
6%
Silencing Effect
6%
Silica-based
12%
Silsesquioxane
25%
Therapeutic Effect
6%
Therapeutic Efficacy
6%
Therapeutic nucleic Acids
25%
Therapeutic Potential
6%
Therapeutic Target
6%
Triple-negative Breast Cancer
50%
United States
6%
Young Age
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antiapoptotic
5%
Breast Cancer
11%
Chemotherapy
5%
Combination Therapy
5%
Malignant Neoplasm
22%
Nanoparticle
50%
Nucleic Acid
11%
Photodynamic Therapy
5%
Photosensitizer
5%
Polyethylene Glycol
11%
Protein Bcl 2
11%
Recurrent Disease
11%
Side Effect
5%
Silicon Dioxide
11%
Therapeutic Effect
5%
Triple Negative Breast Cancer
50%